Source comparison
TB-500 Dosage for Wound Healing: Protocol Comparison
Acute Soft Tissue Injury 5–7mg twice weekly (Monday/Thursday) 2–5mg once weekly Muscle tears, ligament sprains, post-surgical wounds 30–40% faster closure vs baseline at day 14 Chronic Non-Healing Wound 7–10mg twice weekly for 3 weeks 5mg twice weekly ongoing
This comparison does not assign a generated winner or score.
- Acute Soft Tissue Injury
- 5–7mg twice weekly (Monday/Thursday)
- 2–5mg once weekly
- Muscle tears, ligament sprains, post-surgical wounds
- 30–40% faster closure vs baseline at day 14
- Chronic Non-Healing Wound
- 7–10mg twice weekly for 3 weeks
- 5mg twice weekly ongoing
- Diabetic ulcers, pressure sores, radiation-damaged tissue
- Granulation tissue visible by week 2; closure varies by wound etiology
- Burn Recovery
- 6mg twice weekly starting within 24 hours
- 3–5mg weekly through week 8
- Second-degree burns, skin graft donor sites
- Reduced eschar formation; 20–25% less visible scarring at 6 months
- Scar Remodeling (Existing Injury)
- Not applicable. Begin directly at maintenance
- 2–5mg weekly for 6–8 weeks
- Post-surgical scar revision, keloid management
- Modest improvement in scar pliability; tensile strength effects minimal